As of November 15, 2026, AN2 Therapeutics, Inc. has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on August 8, 2024. No WARN notice under its name is on file in the states covered here (Form 8-K, August 8, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of AN2 Therapeutics, Inc.
Free to see. No signup.
People from AN2 Therapeutics, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the AN2 Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
AN2 Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did AN2 Therapeutics have layoffs in 2024? What its filings say
AN2 Therapeutics, Inc. (CIK 1880438) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-08-08
This filing reports Item 2.05, and its section states none of employees affected, share of workforce, locations, charges or timing in a single sentence. The full text is in the filing.
Also on the record for AN2 Therapeutics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by Coastlands Capital LP | 9.99% of the class | 5%+ stakes | Source |
| November 13, 2026 | Stake report, Schedule 13G/A, by Eric Easom | 6.2% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Almitas Capital LLC | 4.1% of the class | 5%+ stakes | Source |
| March 25, 2026 | Form D, private offering | $40M sold | Form D page | Source |
| March 20, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| March 16, 2026 | Stake report, Schedule 13G, by Commodore Capital LP | 9.9% of the class | 5%+ stakes | Source |
| March 13, 2026 | Stake report, Schedule 13G, by Millennium Management LLC | 6.3% of the class | 5%+ stakes | Source |
| March 13, 2026 | Stake report, Schedule 13G, by Vivo Opportunity Fund Holdings, L.P. | 8% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G, by Almitas Capital LLC | 5.4% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Eric Easom | 7.9% of the class | 5%+ stakes | Source |
| January 29, 2026 | Leadership change: Sarah Williams appointed, Vice President, Controller and Principal Accounting Officer | — | Leadership changes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by Almitas Capital LLC | 5.2% of the class | 5%+ stakes | Source |
Keep reading
More on AN2 Therapeutics, Inc. and the records around it.
AN2 Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Form D filing Mar 2026
- Leadership changes Mar 2026
- Who owns it
Companies that share a holder
- Almitas Capital LLC also filed stake reports on 8 other companies: MFS HIGH YIELD MUNICIPAL TRUST (Aug 2026), MFS INVESTMENT GRADE MUNICIPAL TRUST (Aug 2026), ABRDN JAPAN EQUITY FUND, INC. (Feb 2026)
- Coastlands Capital LP also filed stake reports on 17 other companies: Camp4 Therapeutics Corp (Nov 2026), Eloxx Pharmaceuticals, Inc. (Nov 2026), Minerva Neurosciences, Inc. (Nov 2026)
- Vivo Opportunity Fund Holdings, L.P. also filed stake reports on 20 other companies: ArriVent BioPharma, Inc. (Oct 2026), Clene Inc. (Aug 2026), Compass Therapeutics, Inc. (Aug 2026)
Watch AN2 Therapeutics, Inc.
Get an email when AN2 Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with AN2 Therapeutics, Inc.?
Want the whole picture on AN2 Therapeutics, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on AN2 Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AN2 Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for AN2 Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Related
- Ginkgo Bioworks Holdings, Inc.: 3 SEC filings, Aug 2024 layoff notice within 90 days (2024-08-08)
- Heliogen, Inc.: 2 SEC filings, Aug 2024 layoff notice within 90 days (2024-08-06)
- Warner Music Group Corp.: 2 SEC filings, Sep 2024 layoff notice within 90 days (2024-09-19)
Who owns AN2 Therapeutics, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/an2-therapeutics